Pembrolizumab in Combination With Dabrafenib and Trametinib as a Neoadjuvant Strategy Prior to Surgery in BRAF-Mutated Anaplastic Thyroid Cancer. Here, BRAF is linked to thyroid gland undifferentiated (anaplastic) carcinoma.